endonuclease modulators (Ockham Biotech)

N/A

Report date: 2025/03/20 15:10:26
NME

Base Information

Drug Nameendonuclease modulators (Ockham Biotech)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndonucleases modulators
TargetsEndonucleases
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOckham Biotech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOckham Biotech Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A